Form 10-Q RESEARCH FRONTIERS INC For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/20/2026

1. BA
2. SPY
3. USO
4. XFLT
5. GE

6. RTX
7. DPZ
8. EVEX
9. AMC
10. TRV

Top News Most Read Special Reports

May 5, 2016 8:33 AM EDT

E-mail

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For Quarter Ended March 31, 2016 Commission File No. 1-9399

RESEARCH FRONTIERS INCORPORATED
(Exact name of registrant as specified in charter)

Delaware		11-2103466
(State of incorporation or organization)		(IRS Employer
		Identification No.)

240 Crossways Park Drive, Woodbury, N.Y.		11797
(Address of principal executive offices)	(Zip Code)

(516) 364-1902

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No __

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes X No __

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [ ] Accelerated filer [X] Non-accelerated filer [ ] Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes [ ] No [X]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: As of May 5, 2016, there were outstanding 24,043,846 shares of Common Stock, par value $0.0001 per share.

RESEARCH FRONTIERS INCORPORATED
Consolidated Balance Sheets

	March 31,
	2016			December 31,
Assets	(Unaudited)			2015
Current assets:
Cash and cash equivalents	$	4,671,812		$	5,712,310
Short-term investments		1,516,352			1,513,784
Royalty receivables, net of reserves of $629,457 in
2016 and 2015		1,374,214			1,314,675
Prepaid expenses and other current assets		79,228			133,465
Total current assets		7,641,606			8,674,234

Fixed assets, net		790,395			836,216
Deposits and other assets		33,567			33,567
Total assets	$	8,465,568		$	9,544,017

Liabilities and Shareholders’ Equity

Current liabilities:
Accounts payable	$	118,575		$	46,734
Accrued expenses and other		417,119			421,478
Deferred revenue		30,762			-
Total current liabilities		566,456			468,212

Shareholders’ equity:
Common stock, par value $0.0001 per share;
authorized 100,000,000 shares, issued and outstanding
24,043,846 and 24,043,846 shares for 2016 and 2015		2,404			2,404
Additional paid-in capital		111,483,959			111,483,959
Accumulated deficit		(103,587,251	)		(102,410,558	)
Total shareholders’ equity		7,899,112			9,075,805

Total liabilities and shareholders’ equity	$	8,465,568		$	9,544,017

See accompanying notes to consolidated financial statements.

RESEARCH FRONTIERS INCORPORATED
Consolidated Statements of Operations
(Unaudited)

	Three months ended
	March 31, 2016			March 31, 2015
Fee income	$	409,133		$	379,398

Operating expenses		1,186,507			1,172,537
Research and development		410,217			434,454
Total Expenses		1,596,724			1,606,991

Operating loss		(1,187,591	)		(1,227,593	)

Net investment income		10,898			11,216
Net loss	$	(1,176,693	)	$	(1,216,377	)

Basic and diluted net loss
per common share	$	(0.05	)	$	(0.05	)

Weighted average number of
common shares outstanding		24,043,846			23,944,144

See accompanying notes to consolidated financial statements.

RESEARCH FRONTIERS INCORPORATED
Consolidated Statements of Cash Flows
(Unaudited)

	Three months ended
	March 31, 2016			March 31, 2015
Cash flows from operating activities:
Net loss	$	(1,176,693	)	$	(1,216,377	)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization		47,412			8,617
Stock-based compensation		-			67,963
Change in assets and liabilities:
Royalty receivables		(59,539	)		20,776
Prepaid expenses and other current assets		54,237			42,479
Deferred revenue		30,762			32,722
Accounts payable and accrued expenses		67,482			(66,058	)
Net cash used in operating activities		(1,036,339	)		(1,109,878	)

Cash flows from investing activities:
Purchases of fixed assets		(1,591	)		(176,224	)
Change in investments		(2,568	)		(2,382	)
Net cash used in investing activities		(4,159	)		(178,606	)

Cash flows from financing activities:
Net proceeds from exercise of options and warrants		-			245,873
Net cash provided by financing activities		-			245,873

Net decrease in cash and cash equivalents		(1,040,498	)		(1,042,611	)

Cash and cash equivalents at beginning of year		5,712,310			7,569,537
Cash and cash equivalents at end of year	$	4,671,812		$	6,526,926

See accompanying notes to consolidated financial statements.

RESEARCH FRONTIERS INCORPORATED
Notes to Consolidated Financial Statements
March 31, 2016
(Unaudited)

Basis of Presentation

The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the three months ended March 31, 2016 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2016. For further information, refer to the consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K relating to Research Frontiers Incorporated (the “Company”) for the fiscal year ended December 31, 2015.

Business

Research Frontiers Incorporated (“Research Frontiers” or the “Company”) operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Such devices, often referred to as “light valves” or suspended particle devices (SPDs), use colloidal particles that are either incorporated within a liquid suspension or a film, which is usually enclosed between two sheets of glass or plastic having transparent, electrically conductive coatings on the facing surfaces thereof. At least one of the two sheets is transparent. SPD technology, made possible by a flexible light-control film invented by Research Frontiers, allows the user to instantly and precisely control the shading of glass/plastic manually or automatically. SPD technology has numerous product applications, including: SPD-Smart™ windows, sunshades, skylights and interior partitions for homes and buildings; automotive windows; sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels and navigation systems; aircraft windows; eyewear products; and flat panel displays for electronic products. SPD-Smart light control film is now being developed for, or used in, architectural, automotive, marine, aerospace and appliance applications.

The Company has historically utilized its cash and the proceeds from the sale of its investments to fund its research and development of SPD light valves, for marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, and the development of new licensees and changes in the Company’s relationships with its existing licensees. The degree of dependence of the Company’s working capital requirements on each of the forgoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending on the nature of such changes. There can be no assurance that expenditures will not exceed the anticipated amounts or that additional financing, if required, will be available when needed or, if available, that’s its terms will be favorable or acceptable to the Company. Eventual success of the Company and generation of positive cash flow will be dependent upon the commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. To date, the Company has not generated sufficient revenue from its licensees to fund its operations.

Patent Costs

The Company expenses costs relating to the development, acquisition or enforcement of patents due to the uncertainty of the recoverability of these items.

Revenue Recognition

The Company has entered into a number of license agreements covering its light-control technology. The Company receives minimum annual royalties under certain license agreements and records fee income on a ratable basis each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognizes fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and recognized into income in future periods as earned.

Fee Income

Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During the first three months of 2016, four licensees accounted for 10% or more of fee income of the Company; these licensees accounted for approximately 30%, 26%, 14% and 12% respectively of fee income recognized during this period. During the first three months of 2015, three licensees accounted for 10% or more of fee income of the Company; these licensees accounted for approximately 41%, 18% and 13% respectively of fee income recognized during such period.

Stock-Based Compensation

The Company has granted options/warrants to consultants. GAAP requires that all stock-based compensation be recognized as an expense in the financial statements and that such costs be measured at the fair value of the award. These awards generally vest ratably over 12 to 60 months from the date of grant and the Company charges to operations quarterly the current market value of the options using the Black-Scholes method. During the three months ended March 31, 2016 there were no charges related to options granted to consultants. During the three months ended March 31, 2015 a charge of $10,007 was charged to operations reflecting the fair value of the options using the Black-Scholes method with the following weighted average assumptions:

		2015
Risk free interest rate		1.7%
Option Life		8.9 years
Volatility		65%

The Company did not grant any stock options to employees and directors during the three months ended March 31, 2016 and 2015.

In connection with the restricted stock grants to employees and directors, the Company charged $57,956 to operations during the three months ended March 31, 2015. There was no compensation recorded relating to restricted stock grants to employees and directors during the three months ended March 31, 2016.

Income Taxes

Since inception, the Company has incurred losses from operations and as a result has not recorded income tax expense. Benefits related to net operating loss carryforwards and deferred items have been fully reserved since it was not more likely than not that the Company would achieve profitable operations.

Equity

The Company did not sell any equity securities during the three months ended March 31, 2016 and 2015. The Company did not receive any proceeds during the three months ended March 31, 2016 in connection with stock issued by the exercise of options and warrants previously granted. The Company received proceeds of $245,873 during the three months ended March 31, 2015, in connection with stock issued by the exercise of options and warrants previously granted.

Treasury Stock

The Company did not repurchase any of its stock during the three months ended March 31, 2016 and 2015.

Investments

The Company classifies investments in marketable securities as trading, available-for-sale or held-to-maturity at the time of purchase and periodically re-evaluates such classifications. Trading securities are carried at fair value, with unrealized holding gains and losses included in earnings. Held-to-maturity securities are recorded at cost and are adjusted for the amortization or accretion of premiums or discounts over the life of the related security. Unrealized holding gains and losses on available-for-sale securities are excluded from earnings and are reported as a separate component of accumulated other comprehensive income (loss) until realized. In determining realized gains and losses, the cost of securities sold is based on the specific identification method. Interest and dividends on the investments are accrued at the balance sheet date. At March 31, 2016 and December 31, 2015 all investments were classified as held to maturity and consisted of the following:

			March 31, 2016		December 31, 2015
Certificates of Deposit		Maturity	Value of Held to Maturity Investment		Value of Held to Maturity Investment
Investment		Date	(based on cost)		(based on cost)
$	1,513,784	August 27, 2016	$	1,516,352	$	1,513,784

			$	1,516,352	$	1,513,784

Fair Value Measurements

We value financial instruments using a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets or liabilities; Level 2, defined as inputs other than quoted prices for similar assets or liabilities in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

Financial assets accounted for at fair value on a recurring basis at March 31, 2016 include cash, cash equivalents and investments of approximately $6.2 million. These assets are carried at fair value based on quoted market prices for identical securities (Level 1 inputs).

Management’s Discussion and Analysis of
Financial Condition and Results of Operations

Critical Accounting Policies

The following accounting policies are important to understanding our financial condition and results of operations and should be read as an integral part of the discussion and analysis of the results of our operations and financial position. For additional accounting policies, see note 2 to our consolidated financial statements, “Summary of Significant Accounting Policies” in our Form 10-K report for the period ending December 31, 2015.

The Company has entered into a number of license agreements covering products using the Company’s SPD technology. The Company receives fees and minimum annual royalties under certain license agreements and records fee income on a ratable basis each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognizes fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue.

The Company expenses costs relating to the development or acquisition of patents due to the uncertainty of the recoverability of these items. All of our research and development costs are charged to operations as incurred. Our research and development expenses consist of costs incurred for internal and external research and development. These costs include direct and indirect overhead expenses.

The Company has historically used the Black-Scholes option-pricing model to determine the estimated fair value of each option grant. The Black-Scholes model includes assumptions regarding dividend yields, expected volatility, expected lives, and risk-free interest rates. These assumptions reflect our best estimates, but these items involve uncertainties based on market conditions generally outside of our control. As a result, if other assumptions had been used in the current period, stock-based compensation expense could have been materially impacted. Furthermore, if management uses different assumptions in future periods, stock-based compensation expense could be materially impacted in future years.

On occasion, the Company may issue consultants either options or warrants to purchase shares of common stock of the Company at specified share prices. These options or warrants may vest based upon specific services being performed or performance criteria being met. In accounting for equity instruments that are issued to other than employees for acquiring, or in conjunction with selling, goods or services, the Company would be required to record consulting expenses based upon the fair value of such options or warrants on the earlier of the service period or the period that such options or warrants vest as determined using a Black-Scholes option pricing model.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. An example of a critical estimate is the full valuation allowance for deferred taxes that was recorded based on the uncertainty that such tax benefits would be realized in future periods.

Results of Operations

Three months ended March 31, 2016 Compared to the Three months ended March 31, 2015

The majority of the Company's fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company's royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines. In addition to these macro factors, the Company's royalty income from the automotive market could also be influenced by specific factors such as whether the Company's SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within model like produced with SPD-SmartGlass, and changes in pricing or exchange rates.

Certain license fees, which are paid to the Company in advance of the accounting period in which they are earned resulting in the recognition of deferred revenue for the current accounting period, which will be recognized as fee income in future periods. Also, licensees may offset some or all of their royalty payments on sales of licensed products for a given period by applying these advance payments towards such earned royalty payments. Because the Company’s license agreements typically provide for the payment of royalties by a licensee on product sales within 45 days after the end of the quarter in which a sale of a licensed product occurs (with some of the Company’s more recent license agreements providing for payments on a monthly basis), and because of the time period which typically will elapse between a customer order and the sale of the licensed product and installation in a home, office building, automobile, aircraft, boat or any other product, there could be a delay between when economic activity between a licensee and its customer occurs and when the Company gets paid its royalty resulting from such activity.

The Company’s fee income from licensing activities for the three months ended March 31, 2016 was $409,133, as compared to $379,398 for the three months ended March 31, 2015 representing a $29,735 increase between these two periods. This increase was principally the result of higher royalties from automotive and aircraft licensees. In the first quarter of 2016, the Company received royalty revenues for fiscal 2016 from sales of the Magic Sky Control option on the S-Class in excess of minimum annual royalty levels for one of our licensees which therefore will be accretive to the Company's royalty revenue. The Company also received royalties from another one of our licensees in excess of minimum annual royalty levels from sales of the Magic Sky Control option on the SLK and SL vehicles which also are accretive to the Company's royalty revenues. Production efficiencies are expected to continue and accelerate with the introduction of the higher vehicle production volumes for various car models going forward, and the Company expects that lower pricing per square foot of the Company’s technology could expand the market opportunities, adoption rates, and revenues for its technology in automotive and non-automotive applications.

Operating expenses increased by $13,970 for the three months ended March 31, 2016 to $1,186,507 from $1,172,537 for the three months ended March 31, 2015. This increase was principally the result of amortization costs relating to trade show displays ($39,000) as well as higher payroll ($30,000) partially offset by lower marketing and investor relations costs ($13,000), lower professional fees ($18,000) and lower insurance costs ($10,000).

Research and development expenditures decreased by $24,237 to $410,217 for the three months ended March 31, 2016 from $434,454 for the three months ended March 31, 2015. This decrease was principally the result of lower allocated facility costs ($14,000) as well as lower material costs ($14,000).

The Company’s net investment income for the three months ended March 31, 2016 was $10,898 compared to $11,216 earned for the three months ended March 31, 2015.

As a consequence of the factors discussed above, the Company’s net loss was $1,176,693 ($0.05 per common share) for the three months ended March 31, 2016 as compared to $1,216,377 ($0.05 per common share) for the three months ended March 31, 2015.

Financial Condition, Liquidity and Capital Resources

The Company has primarily utilized its cash, cash equivalents, short-term investments, and the proceeds from its investments to fund its research and development, for marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including, but not limited to, the results of research and development activities, competitive and technological developments, the timing and costs of patent filings, and the development of new licensees and changes in the Company’s relationship with existing licensees. The degree of dependence of the Company’s working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes.

During the three months ended March 31, 2016, the Company’s cash and cash equivalents balance decreased by $1,040,498. The decline was mainly due to cash used for operations of $1,036,339 and the purchase of fixed assets of $1,591 and increase in investments of $2,568. As of March 31, 2016 the Company had working capital (total current assets less total current liabilities) of $7,075,150 and total shareholder’s equity of $7,899,112.

The Company expects to use its cash to fund its research and development of SPD light valves, its expanded marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, the development of new licensees and changes in the Company’s relationships with its existing licensees. The degree of dependence of the Company’s working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes. Based upon existing cash reserves and historical revenues and cash expenditures, the Company believes that its current cash and cash equivalents would fund operations through early 2018. There can be no assurances that expenditures will not exceed the anticipated amounts or that additional financing, if required, will be available when needed or, if available, that its terms will be favorable or acceptable to the Company. Eventual success of the Company and generation of positive cash flow will be dependent upon the extent of commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. To date the Company has not generated sufficient revenue from licensees to fund its operations.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The information required by Item 3 has been disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. There has been no material change in the disclosure regarding market risk.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We designed our disclosure controls and procedures to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officer, to allow timely decisions regarding required disclosure. Our chief executive officer and chief financial officer, with assistance from other members of our management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2016, and, based on their evaluation, have concluded that our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the three months ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Forward-Looking Statements

The information set forth in this Report and in all publicly disseminated information about the Company, including the narrative contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” above, includes “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by that section. Readers are cautioned not to place undue reliance on these forward-looking statements as they speak only as of the date hereof and are not guaranteed.

PART II. OTHER INFORMATION

Item 6.		Exhibits
31.1		Rule 13a-14(a)/15d-14(a) Certification of Joseph M. Harary - Filed herewith.
31.2		Rule 13a-14(a)/15d-14(a) Certification of Seth L. Van Voorhees - Filed herewith.
32.1		Section 1350 Certification of Joseph M. Harary - Filed herewith.
32.2		Section 1350 Certification of Seth L. Van Voorhees - Filed herewith.
EX-101.INS		XBRL Instance Document
EX-101.SCH		XBRL Taxonomy Extension Schema
EX-101.PRE		XBRL Taxonomy Extension Presentation Linkbase
EX-101.LAB		XBRL Taxonomy Extension Label Linkbase
EX-101.CAL		XBRL Taxonomy Extension Calculation Linkbase
EX-101.DEF		XBRL Taxonomy Extension Definition Linkbase

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.

	RESEARCH FRONTIERS INCORPORATED
	(Registrant)


	/s/ Joseph M. Harary
	Joseph M. Harary, President, CEO and Treasurer
	(Principal Executive)


	/s/ Seth L. Van Voorhees
	Seth L. Van Voorhees, Vice President, CFO and Treasurer
	(Principal Financial and Accounting Officer)

Date: May 5, 2016

EXHIBIT 31.1 CERTIFICATION

I, Joseph M. Harary, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Research Frontiers Incorporated (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer’s and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer’s and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: May 5, 2016	/s/ Joseph M. Harary
	Joseph M. Harary
	President, Chief Executive Officer

EXHIBIT 31.2 CERTIFICATION

I, Seth L. Van Voorhees, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Research Frontiers Incorporated (the “registrant”);

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: May 5, 2016	/s/ Seth L. Van Voorhees
	Seth L. Van Voorhees
	Vice President, Chief Financial Officer,
	Treasurer and Principal Accounting Officer

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Research Frontiers Incorporated (the “Company”) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Joseph M. Harary, President and Chief Executive Officer and Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.		The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Joseph M. Harary
Joseph M. Harary
President, Chief Executive Officer and Principal Executive Officer
May 5, 2016

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Research Frontiers Incorporated (the “Company”) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Seth L. Van Voorhees, Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.		The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Seth L. Van Voorhees
Seth L. Van Voorhees
Vice President, Chief Financial Officer,
Treasurer and Principal Accounting Officer
May 5, 2016

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2016	May. 05, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	RESEARCH FRONTIERS INC
Entity Central Index Key	0000793524
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		24,043,846
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1

Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 4,671,812	$ 5,712,310
Short term investments	1,516,352	1,513,784
Royalty receivables, net of reserves of $629,457 in 2016 and 2015	1,374,214	1,314,675
Prepaid expenses and other current assets	79,228	133,465
Total current assets	7,641,606	8,674,234
Fixed assets, net	790,395	836,216
Deposits and other assets	33,567	33,567
Total assets	8,465,568	9,544,017
Current liabilities:
Accounts payable	118,575	46,734
Accrued expenses and other	417,119	$ 421,478
Deferred revenue	30,762
Total current liabilities	566,456	$ 468,212
Shareholders' equity:
Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 24,043,846 and 24,043,846 shares for 2016 and 2015	2,404	2,404
Additional paid-in capital	111,483,959	111,483,959
Accumulated deficit	(103,587,251)	(102,410,558)
Total shareholders' equity	7,899,112	9,075,805
Total liabilities and shareholders' equity	$ 8,465,568	$ 9,544,017

Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Consolidated Balance Sheets [Abstract]
Royalty receivables, reserves	$ 629,457	$ 629,457
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	24,043,846	24,043,846
Common stock, shares outstanding	24,043,846	24,043,846

Consolidated Statements of Operations - USD ($)	3 Months Ended
Consolidated Statements of Operations - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Consolidated Statements of Operations [Abstract]
Fee income	$ 409,133	$ 379,398
Operating expenses	1,186,507	1,172,537
Research and development	410,217	434,454
Total Expenses	1,596,724	1,606,991
Operating loss	(1,187,591)	(1,227,593)
Net investment income	10,898	11,216
Net loss	$ (1,176,693)	$ (1,216,377)
Basic and diluted net loss per common share	$ (0.05)	$ (0.05)
Weighted average number of common shares outstanding	24,043,846	23,944,144

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net loss	$ (1,176,693)	$ (1,216,377)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	$ 47,412	8,617
Stock-based compensation		67,963
Change in assets and liabilities:
Royalty receivables	$ (59,539)	20,776
Prepaid expenses and other current assets	54,237	42,479
Deferred revenue	30,762	32,722
Accounts payable and accrued expenses	67,482	(66,058)
Net cash used in operating activities	(1,036,339)	(1,109,878)
Cash flows from investing activities:
Purchases of fixed assets	(1,591)	(176,224)
Change in investments	(2,568)	(2,382)
Net cash used in investing activities	$ (4,159)	(178,606)
Cash flows from financing activities:
Net proceeds from exercise of options and warrants		245,873
Net cash provided by financing activities		245,873
Net decrease in cash and cash equivalents	$ (1,040,498)	(1,042,611)
Cash and cash equivalents at beginning of year	5,712,310	7,569,537
Cash and cash equivalents at end of year	$ 4,671,812	$ 6,526,926

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2016
Basis of Presentation [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the three months ended March 31, 2016 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2016. For further information, refer to the consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K relating to Research Frontiers Incorporated (the “Company”) for the fiscal year ended December 31, 2015.

Business	3 Months Ended
Business	Mar. 31, 2016
Business [Abstract]
Business	Business Research Frontiers Incorporated (“Research Frontiers” or the “Company”) operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Such devices, often referred to as “light valves” or suspended particle devices (SPDs), use colloidal particles that are either incorporated within a liquid suspension or a film, which is usually enclosed between two sheets of glass or plastic having transparent, electrically conductive coatings on the facing surfaces thereof. At least one of the two sheets is transparent. SPD technology, made possible by a flexible light-control film invented by Research Frontiers, allows the user to instantly and precisely control the shading of glass/plastic manually or automatically. SPD technology has numerous product applications, including: SPD-Smart™ windows, sunshades, skylights and interior partitions for homes and buildings; automotive windows; sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels and navigation systems; aircraft windows; eyewear products; and flat panel displays for electronic products. SPD-Smart light control film is now being developed for, or used in, architectural, automotive, marine, aerospace and appliance applications. The Company has historically utilized its cash and the proceeds from the sale of its investments to fund its research and development of SPD light valves, for marketing initiatives, and for other working capital purposes. The Company's working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, and the development of new licensees and changes in the Company's relationships with its existing licensees. The degree of dependence of the Company's working capital requirements on each of the forgoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending on the nature of such changes. There can be no assurance that expenditures will not exceed the anticipated amounts or that additional financing, if required, will be available when needed or, if available, that's its terms will be favorable or acceptable to the Company. Eventual success of the Company and generation of positive cash flow will be dependent upon the commercialization of products using the Company's technology by the Company's licensees and payments of continuing royalties on account thereof. To date, the Company has not generated sufficient revenue from its licensees to fund its operations.

Patent Costs	3 Months Ended
Patent Costs	Mar. 31, 2016
Patent Costs [Abstract]
Patent Costs	Patent Costs The Company expenses costs relating to the development, acquisition or enforcement of patents due to the uncertainty of the recoverability of these items.

Revenue Recognition	3 Months Ended
Revenue Recognition	Mar. 31, 2016
Revenue Recognition [Abstract]
Revenue Recognition	Revenue Recognition The Company has entered into a number of license agreements covering its light-control technology. The Company receives minimum annual royalties under certain license agreements and records fee income on a ratable basis each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognizes fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and recognized into income in future periods as earned.

Fee Income	3 Months Ended
Fee Income	Mar. 31, 2016
Fee Income [Abstract]
Fee Income	Fee Income Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During the first three months of 2016, four licensees accounted for 10% or more of fee income of the Company; these licensees accounted for approximately 30%, 26%, 14% and 12% respectively of fee income recognized during this period. During the first three months of 2015, three licensees accounted for 10% or more of fee income of the Company; these licensees accounted for approximately 41%, 18% and 13% respectively of fee income recognized during such period.

Stock-Based Compensation

3 Months Ended

Mar. 31, 2016

Stock-Based Compensation [Abstract]

Stock-Based Compensation

	2015
Risk free interest rate		1.7	%
Option Life		8.9	years
Volatility		65	%

The Company did not grant any stock options to employees and directors during the three months ended March 31, 2016 and 2015.

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2016
Income Taxes [Abstract]
Income Taxes	Income Taxes Since inception, the Company has incurred losses from operations and as a result has not recorded income tax expense. Benefits related to net operating loss carryforwards and deferred items have been fully reserved since it was not more likely than not that the Company would achieve profitable operations.

Equity	3 Months Ended
Equity	Mar. 31, 2016
Equity [Abstract]
Equity	Equity The Company did not sell any equity securities during the three months ended March 31, 2016 and 2015. The Company did not receive any proceeds during the three months ended March 31, 2016 in connection with stock issued by the exercise of options and warrants previously granted. The Company received proceeds of $245,873 during the three months ended March 31, 2015, in connection with stock issued by the exercise of options and warrants previously granted.

Treasury Stock	3 Months Ended
Treasury Stock	Mar. 31, 2016
Treasury Stock [Abstract]
Treasury Stock	Treasury Stock The Company did not repurchase any of its stock during the three months ended March 31, 2016 and 2015.

Investments

3 Months Ended

Mar. 31, 2016

Investments [Abstract]

Investments

			March 31, 2016		December 31, 2015
Certificates of Deposit		Maturity	Value of Held to Maturity Investment		Value of Held to Maturity Investment
Investment		Date	(based on cost)		(based on cost)
$	1,513,784	August 27, 2016	$	1,516,352	$	1,513,784
			$	1,516,352	$	1,513,784

Fair Value Measurements	3 Months Ended
Fair Value Measurements	Mar. 31, 2016
Fair Value Measurements [Abstract]
Fair Value Measurements	Fair Value Measurements We value financial instruments using a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets or liabilities; Level 2, defined as inputs other than quoted prices for similar assets or liabilities in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Financial assets accounted for at fair value on a recurring basis at March 31, 2016 include cash, cash equivalents and investments of approximately $6.2 million. These assets are carried at fair value based on quoted market prices for identical securities (Level 1 inputs).

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2016

Stock-Based Compensation [Abstract]

Schedule of Assumptions Used to Value Options Granted to Consultants

	2015
Risk free interest rate		1.7	%
Option Life		8.9	years
Volatility		65	%

Investments (Tables)

3 Months Ended

Mar. 31, 2016

Investments [Abstract]

Schedule of Investments

			March 31, 2016		December 31, 2015
Certificates of Deposit		Maturity	Value of Held to Maturity Investment		Value of Held to Maturity Investment
Investment		Date	(based on cost)		(based on cost)
$	1,513,784	August 27, 2016	$	1,516,352	$	1,513,784
			$	1,516,352	$	1,513,784

Fee Income (Details) - Sales [Member]	3 Months Ended
Fee Income (Details) - Sales [Member]	Mar. 31, 2016	Mar. 31, 2015
Licensee One [Member]
Product Information [Line Items]
Percentage of fee income	30.00%	41.00%
Licensee Two [Member]
Product Information [Line Items]
Percentage of fee income	26.00%	18.00%
Licensee Three [Member]
Product Information [Line Items]
Percentage of fee income	14.00%	13.00%
Licensee Four [Member]
Product Information [Line Items]
Percentage of fee income	12.00%

Stock-Based Compensation (Schedule of Assumptions Used to Value Options Granted to Consultants) (Details)	3 Months Ended
	Mar. 31, 2015
Share-based Goods and Nonemployee Services Transaction [Line Items]
Risk free interest rate	1.70%
Option Life	8 years 10 months 24 days
Volatility	65.00%

Stock-Based Compensation (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Charge recorded		$ 10,007
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Charge recorded		$ 57,956
Minimum [Member] \| Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	12 months
Maximum [Member] \| Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	60 months

Equity (Details) - USD ($)	3 Months Ended
Equity (Details) - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Equity [Abstract]
Net proceeds from exercise of options and warrants		$ 245,873

Investments (Details) - USD ($)	3 Months Ended
Investments (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Certificates of Deposit [Member]
Schedule of Held-to-maturity Securities [Line Items]
Value of Held to Maturity Investments (based on cost)	$ 1,516,352	$ 1,513,784
Certificate Of Deposits One [Member]
Schedule of Held-to-maturity Securities [Line Items]
Certificates of Deposit Investment	$ 1,513,784
Maturity Date	Aug. 27, 2016
Value of Held to Maturity Investments (based on cost)	$ 1,516,352	$ 1,513,784

Fair Value Measurements (Details) $ in Millions	Mar. 31, 2016 USD ($)
Fair Value Measurements [Abstract]
Financial assets at fair value	$ 6.2

begin 644 Financial_Report.xlsx
M4$L#!!0    (  1$I4C[QI0%D@$  #$1   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,U8RT[#,!#\[email protected]!YJ>Z%W!/B\@HD0&#AST0:T\39HS@.?-<*U*KHE5UJ,N2
MYU#H?"U#2NH#-5P$/!DLF/5/3(829"M( ^R?-(TX.0^A,Q98X2H +T7J_$Z 
MZ^+?(Q_,^39. NJ,8VHF_*>,R-LVH
MY;>,./_C6EJ;6$LQMVS#6P1U;VV*8RH95UVMVFB[>M-Z=+%V]#?[KOQ-: _';&OS?M/
M36] 1YJA1Y,X24>&1,QW8OG*\M"_V/Z'D4X$G1H>)%]2-F Q+M*;V"^GH A3&^
M.R6:E((C-Z."N[_8_ )02P,$%     @ !$2E2+:A'7%. 0  Q0\  !H   !X
M;"]?J$.Y6@4A>M&LP%.+-NKMO$8.7\PTVTP;3\F/$_VQOZ[HK\6K+UP%-^*-"
M?FT@9#Q(Q8,42] V'K1E"=K%@W8L0?MXT)XE*(L'92Q!AWC0@27H& \ZL@2=
MXD$GEB!("1E3GB0*:QZM@> :>+P& FS@$1L(LH'';"#0!AZU@6 ;>-P& F[@
MD1L(NH'';B#P!AZ]%:&WXM%;$7HKIK,V==CFT5L1>BL>O16AM^+16RWT]JUV
M6#T'UYG&KUWS;3A9M,#;AT>/ZZ?,4\F&A=9AV@GE?%W]VYJG?H;(7W_LEP]0
M2P,$%     @ !$2E2!$.I5M" @  5@<  !    !D;V-0&UL
MO55-C]HP$/TK5D[;PVXH0CT@-E+YJ%JIVT4+2\^SSH18.';J,0CZZSM)( U+
M4KH]E OCF3T\_^ZI=C*8NFT6O)\
M%(@7("S,^V '3H'Q@2#UDX_]H&I;>4M;Y^1=]-VZ#:6(GD9A[2S-)K9IJT'4
M'Y0(MLZ18K$ SZX>R&'9CNWB)FR6\Z'8M&OV/,'IW15-Q,T4/2G< NZ=8
M\$\Q?F/.-W"N_7)7NE\9YHS>'Y$=0I^R+IZUYOOTZC4*S_]%HU]02P,$%   
M  @ !$2E2&CD"PT^ 0  :0,  !$   !D;V-0WIZY\>*,.RKG(?
M=5_5-,VXF5)=&KA@;XO'9_HW(VTC"BLAJ:+FV'J89Z?.K].[^^5#5DWR8C;*
MK].SS&_X=,+SXOTPV9F_P;#IAOBWCD\&:;NHL88+=TL:1621A'^_
M1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=
MAIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQS
MYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V@S&L%&KQMUAVC2/'K^
M!?F<-0HACA*FNVB<5@$
M_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W
M-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2
M';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(Y
MV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M
M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1
MDN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?
M]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2D 83  >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K
M8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/
M%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1
M!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (  1$I4AO!NB23@( 
M -8*   -    >&PO]E89,,22/Y@Q&>FOGS\($*2T2==MX<77Q_>>>^QKN(25VE#\L,)8
M@8917D5PI53YV?.J=(49JJ:BQ%ROY$(RI/14%EY52HRRR@0QZLU\?^XQ1#B,
M0UZS!5,52$7-500_=A!P\;9KLZHI\?2?\<^8CZZCCJ9YA'Q->&V&O//@YSP?L2
MS* #XK!Z FM$M7]@W%-!A01*UU@KL A'##N/6T1)(HD!<\0(W3AX9@![+5H_
M1KB0-K?+,,XS]?M,LD@BZ+?/X>F2GMT.9GN$TMWM:2 .2Z04EGRA)Z"UEYM2
M;XX+CIU(Z_>"=R'1)IA=#@+LH/,F0F98=ID#N(7BD.)XFQPX'U-C'P*C8FOJ@VC-_AK80_6&
M;(Y[2/LZ7M#D70(=CXD^V$,?AVC+"E9"DB?M;RY"
MJ@$L(5ACJ4@Z1'Y)5"YQH]H;[#7Y/H6OW?+?U/3VI]:KT5?P7Q_/?TT^K(U]
M#>%(SP&EN*M9@N7"?IF/%_;AZE25F9YYLM+FIROMA MZ_8?2O+8S#-K/3O/I
M4)#4A"K"MQJ0^5VX,[KI3E_H&X_FS)J^Y]A5A1+]D[F319-E.$PH(MC;WW%&:O;)*NC_9./?4$L#!!0    (  1$I4B+L@6=
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M!6Y"P==0P;#"1>;F!A5BF/.),5-Y<2^7!
M7@H/WZVI2JD?T8NSE;3.ST.X]9>%U+*0K^'>N')KL_UAK'PUV@LUSZQ1JE:%
M%[4(3W!_=_".7F:M#[U8WH=*I'P4H>%&.KF42OJ7E-?/"D(D_7>AU.E_>V*Z
M3LZ^Q$SHG%UICRYLJIOB86K"'?#C:5X?;,<2'^PTCYM44:,)@F&4S#$7.;L0
M2N@,6!V.(R8),4D^9<)Z,T&,CHC1T3^,YAY_0I".F16[*\$2HP$Q&GS*:"+<
MFA@-B='PT.A".%G+9A8<6KQ/[XC(1QWRRDD-CN;RF"B.#Q4SO"O6=6)@*V#UDYE'+=Y<\)>+30_$U ,*3F0(H-Q$%)SI4S;W)GKYB?C##
M$U-@^W '[+7@ZZ"O.94MQ#/08&/*6]P!W-7O"HFG"@I6W$'6 EN9J^P+JZ]-
ME92DN .EJ=Y@!ZOQH3+*3=P!SK60ECT(A46YJ8^& PO*3MP!ST<99CUL-:I5
M+ I5W$$5"6*G=E^HGN(5=_#UA@CK78(74K7UE+"X [&/0YGC_,EIJZ'<)9_@
MCO5NA;6TV204OZ0#OP:CSHB25LOK0+"5T2X#2F320>0'@.S-J!5%-!GLIL3;
M8,#9B$TF#V/3U4AR&(\ZY2:H)[=_JG$?6H
M:)SWT_/\#U!+ P04    "  $1*5(P79D*T("  "-!P  &    'AL+W=O$L;_>;,14V4GHI+*%M!RF-@-G_D_,U,OI]V063V0!DME E!].-&#Y0Q$TF3?_=!/YC&Z(_OT;_:=/7V
MCT32 V>_JI,J]6ZC )SHF5R9>N7=-]KGD)B !6?2_H+B*A6O[Y8 U.3=/:O&
M/COW)L:];=Z >@,:#.C_!MP;\&" L"=T"VQ/S;<*OEP@31
MD8%.1MJI_5QN]99'67@S84:*O5,@JX"#(M2Q9P%H#-@CSX[F  =?@1\#\"0#
M;.W8VN/']GABCZT]MO9D]@/XBO0Q()D $L^^&@,:!W"*U"DV.$$+TD@GE-2C
MK&?3\!6;QX#5!+#R['"^4D:2!:6RGB#6OG^V5O8CR8)BV4P0&]\?SR)&DN0Q
M D;3(Q7Y$=+Y0S72K!90/AUXRD)Q%.-UO*""(9JRD,_:S!9Q
MK^E9$5S"F1YEB#T.^L=UY#2)TTRK+/1NOYJ*B^T*$A3\VBAWS0VK0^=Y1O;V
M_)#G64LN] <1EZJ1X,B5OH/M]7OF7%&]B>A)']E2]\9APNA9F>%*CX7K%FZB
M>'MO?D,'SO\"4$L#!!0    (  1$I4BI9VKS/@,  $X-   8    >&PO=V]R
M:W-H965T&ULC9?+@BIB-0?)_CC[=?HGUR=8OS<&8-GHOBZJY6QW:]G@;
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M9EW;4]0.;%LSZ>#_%BBE@-G1@DJI=PJ4 ##>E2K!,** -R
MG8=[/!SSR"#/()&]! 1()L(\GHXIO6!\A,C\0\.L@C43LJH6%5*B38!H(TB2H&<:$#"ZP=%XURP+$
M-RN":8(;YG[4C+UV*T+(\-J9"!/!.8$E3/\9*"#S8@O,#WSW XI[%=QV]Z-F
M7.F@A0I/^43G-N>2!0B^G0+V4Q;VTU$S-@0*(+AU4I@8KW,5I1<0^88*V%%9
MV%$!6R4C2LZ<59-42V;<=U/ =LK"]@78)X647(0=8]2=SR5-T;$T3^3[*4B\
M!I,%&7P3!.R"/[email protected]Y
M?#,$[(9\QG^PT7T"PH165 3[D/I:RH$(L6"#4-\9*79&SH)D%!N>TDD",W>@
MB3 A2FBRX%REOC-2P$QA7QLUZJI;3X1AMX[1S?>8/9L?6?V<5TWT9%MWB>[O
MSWMK6^/2D1NW[P[NX^92*,R^[5Z5>Z^'Z_Y0:.WQ_/5R^83:_ 502P,$%   
M  @ !$2E2%:R2GOP 0  ^ 4  !@   !X;"]W;W)KO;MQXOMJ*%N
MO:B S^_/@PKEQ/B[Z#"6P0,42=7E9R!&
MCE%C0I2 &,(<4-0/856:L5=>E>PB23_@5QZ("Z6(_SY@PJ9]&(6W@;?^W$D]
M *H2W'--3_$@>C8$'+?[\%.TJPM-&.!'CR?AM /M?F3L77>^-?L0:@5,\$GJ
M"DA=KKC&A.A":N)?<\V_4^J@V[Y5_V)6J^R/2.":D9]](SLE"\.@P2VZ$/G&
MIJ]X7D*F"YX8$>8_.%V$9/06"0.*/NRU'\QULG>R=([Y _$B7@A$9M\8B7R?^>313XQ^=3FBT?%P2["(H5!\O@ES;Q8
MO8(]M4D7-JEKL_7:6&1K$+B!$$9>FQ7LJ4VVL,EOC45R@T1P_GF%ULFG
M3OG"*7><,N],A]R9*4YAFFR=#\-56@6?&A4+H\(U\KZ,0_&_1JN@-0+.)AW1
M&7]'_-P/(C@RJ?:[V>HM8Q*K3+8CV7@[9^^'
M??4'4$L#!!0    (  1$I4@J[J9*G@(  ,T(   8    >&PO=V]R:W-H965T
M&ULC9;-CILP%(5?!;'OX#\,'A&D@:IJ%Y5&LVC7GL1)T !.
ML3.9OGV-G1!#W2:;8)MS[OTN#KX4)SF\J;T0.OKHVEZMXKW6A\N]Z+AZ
MD ?1FSM;.715C&,+PLOS6ZOQX6D+)+)MVDZT:M&]M$@MJOX"3[6$(T2J_C1B)/R
MQM$(_RKEVSCYMEG%8&00K5CK,00WEW=1B[8=(YG,O\Y!KSE'HS^^1/]BRS7X
MKUR)6K8_FXW>&UH01QNQY<=6O\C35W&N(1T#KF6K[&^T/BHMNXLECCK^X:Y-
M;Z\G=R?%9UO8@,X&-!FF/&$#/AOPU4!LI8[,UO69:UX6@SQ%ZL#'W8:/1CZ,
M04SDR!2C[-0^+K?Z7J:H2-['.#-)Y23(2N"D2$SP8 8TSU ASQY,4/N*%-_.
M@!BGIY" 0(AG%F,DS(/7N5+6@R
MGR8/TF1^U2FC&2)!G)F. LK8'?_N?,&3^SPLR)-[>3Z9[J[$C!!(EF]:XG6)3@P[VSU5M);'7KNC>%J=.O23;="+]6KLW+;[7,.4
MQ8'OQ'<^[)I>1:]2FQYFV]=62BT,(G@P)]/>?%M,DU9L]3C,S'APW=9-M#Q<
M/AZF+YCR#U!+ P04    "  $1*5(Q\]P@F<#  ###0  &    'AL+W=O:6?ZZ@YEF56_UGJPIP>9W1V[GC)=_NVZX@7\_C"V^2EKIK<5%&MMX^S)_JP
M M9!'.)GKD\->H\Z\:_&O'6-[YO'&>DTZ$*OVRY$9A_O>J6+HHMD,_\>@G[F
M[(CX_1S]JRO7RG_-&KTRQ:]\T^ZM6C*+-GJ;'8OVQ9R^Z:$&T05A%T1L@P7N"(5K$@BH5QQ"L%R>I1TJ$32":4H3XK"
M4I+@ L,0%E2[4DB'5*F+@N,5(KTN!\K#R871_ )RCRS8]B
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M(;FW_K:W-ZI+H]#;MGM5]KWN[QA]HS6'\Y7I##;&34MS\VX'$>4M7]%1X$OW@0H'5%5MXK5"@
MK4!-#'1;>K?:[,J B(!G ;,]BTGPOD=\#UJ%CNN<_A3%D?8Y(3\2\H5PFT7CJ5&T^< =KRN#,[$C#V>W
MVGBX"2)>F7AO-J9Q^E0]U+=%Q0Y!YP*R2Y \0E8+@GGQ3SODEQUV^1D]_YY>
M7!DL(KU(!LOO^>45OXS\\JL!+R#KJQ;L;#\5F#Y>&TL:G+1+&[=4EYMYE\?S
M^(#7UW3^[email protected](?L9DW)X-_.DDCH7 A_^MBDZY02A^/I
M<2POM/X/4$L#!!0    (  1$I4C]?L"RGP$  *T#   8    >&PO=V]R:W-H
M965T&ULA5/+;MLP$/P5@A\0RK23&(8L($Y0M(<"00[MF996
M$A&2JY"4E?Y]^; 5VPB2B[B[FIF=Y:.^V'#F*M[T,+=
MX  F_&G1:N%#:COF!@NB222M&"^*.Z:%-+0J4^W95B6.7DD#SY:X46MA_^U 
MX;2E"WHJO,BN][' JI+-O$9J,$ZB(1;:+7U8;':KB$B /Q(F=Q:3Z'V/^!J3
M7\V6%M$"**A]5!!A.< C*!6%0N.WH^9'RT@\CT_J/]*TP?U>.'A$]565PF>C+;/#^>_[JBK]*_-57 UY UE-(WOTX533@;:('H*'XN:6
MDCZ\G3E1T/H8WH?8YNN4$X_#Z7',+[3Z#U!+ P04    "  $1*5(YJ&OO* !
M  "M P  &    'AL+W=O!A)<3#[K.;3!(+VY.UG0;^'MMI0Z@0O,0SDW/.G/&E&-$^
MNP[ DQ>MC-O1SOM^RYBK.M#"76$/)OQIT&KA0VI;YGH+HDXDK1C/LA],"VEH
M6:3:HRT+'+R2!AXM<8/6PK[N0>&XHRMZ+CS)MO.QP,J"S;Q::C!.HB$6FAV]
M76WW>40DP%\)HUO$)'H_(#['Y*'>T2Q:  65CPHB+$>X Z6B4&C\_Z3YWC(2
ME_%9_7>:-K@_" =WJ/[)VG?!;$9)#8T8E'_"\1Y.(UQ'P0J52U]2#)E6J5)ZSC]X?F)]CF!GPA\)MQDR?C4*-G\);PH"XLC<;V(9[?:!KB-(D&9
M!&\NI6GZJ7HL;S8%.T:=#Y#]!.$)LIH1+(A_VH%_[+#G"SK_GKZ^,+A.]'6B
M;[+O^?D%/T_\_*L!EY#-Y81LL9\:;)NNC2,5#L9/&S=7YYMYR]-YO,/+HA&PO=V]R:W-H965T&ULA5/;;J,P$/T5RQ]0@Z%[B0A2TVJU^[!2U8?=9P<&L&I[J&U"
M]^_7-@E-HJI]P3/#.6?.^%+-:)_= .#)JU;&;>G@_;AAS#4#:.%N< 03_G1H
MM? AM3USHP71)I)6C&?9%Z:%-+2N4NW1UA5.7DD#CY:X26MA_^U X;RE.3T5
MGF0_^%A@=<567BLU&"?1$ O=EM[EFUT9$0GP1\+LSF(2O>\1GV/RJ]W2+%H 
M!8V/"B(L![@'I:)0:/QRU'QK&8GG\4G]1YHVN-\+!_>H_LK6#\%L1DD+G9B4
M?\+Y)QQ'N(V"#2J7OJ29G$=]HE"BQ>NR2I/6>?E3Y$?:^P1^)/"5\"U+QI=&
MR>:#\**N+,[$C2*>7;X)0\JH%.]M/#;9/U\:1
M!B?CEXU;J^O-O./I/-[@=36*'GX+VTOCR!Y].-5TH!VBA^ AN[FE9 AO9TT4
M=#Z&7T-LE^NT)!['T^-87VC]'U!+ P04    "  $1*5($P *6)\!  "M P  
M&0   'AL+W=OP),W
MK8S;TM[[8<.8JWO0PMW@ ";\:=%JX4-J.^8&"Z)))*T8+XI;IH4T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M9(\^G&HZT!;10_!0W*PIZ&PO=V]R:W-H965T=^!Q&E+-\COH3DL=G2+%@ ";4+"MPO
M![@#*8.0;_QZU/QL&8C+^*1^'Z?U[O?;4=) RT?IGG%Z@.,(
MET&P1FGCE]2C=:A.%$H4?TNKT'&=TI_5U9'V/:$X$HJ9<)U%XZE1M/F;.UZ5
M!B=B!Q[.+M]XN DB7IEX;S:FGBO;&DQE&[
MM'-S=;Z:MT4\D$]X50Z\@S_<=$);LD?GCS6>:(OHP)O(+BXIZ?WCF1,)K0OA
M+Q^;=)]2XG XO8[YB58?4$L#!!0    (  1$I4AAE,.BGP$  +$#   9    
M>&PO=V]R:W-H965TV.
M#LZ-6\9L,X#B]@9'T/Y/AT9QYU/3,SL:X&TD*2D
MT/!BB)V4XN;W'B3..YK34^%5](,+!597;.6U0H&V C4QT.WH?;[=EP$1 3\$
MS/8L)L'[ ?$M)$_MCF;! DAH7%#@?CG" T@9A'SC7XOF1\M /(]/ZM_CM-[]
M@5MX0/E3M&[P9C-*6NCX)-TKSH^PC' ;!!N4-GY),UF'ZD2A1/'WM H=USG]
M*.I4;3YC3M>5P9G8D<>SB[?>K@)(EZ9>&\VIG'Z5#W6
M>997[!B$+C#[A"D29D4PK_YIB^*RQ;XXHQ?_IF^N'&XB?;,X_ ^!\DJ@C +E
M7T>\Q&RNFK"S/55@^GAU+&EPTBYMWEI=;^=]$<_D UY7(^_AF9M>:$L.Z/S)
MQD/M$!UX$]G-+26#?S]K(J%S(?SB8Y.N5$H&UL
MA5/+3L,P$/P5RQ^ TS0%5*61* C! 0EQ@+.;;!(+VQMLIX&_QW;2T%8(+O'N
M9F9VUH]\0/-N6P!'/I74=D-;Y[HU8[9L07%[@1UH_Z=&H[CSJ6F8[0SP*I*4
M9&F27#+%A:9%'FO/ILBQ=U)H>#;$]DIQ\[4%B<.&+NBA\"*:UH4"*W(V\RJA
M0%N!FABH-_1FL=YF 1$!KP(&>Q23X'V'^!Z2QVI#DV !))0N*'"_[.$6I Q"
MOO''I/G3,A"/XX/Z?9S6N]]Q"[#P -,(JR!8HK3Q
M2\K>.E0'"B6*?XZKT'$=IC_7$^UW0CH1TIEPG43C8Z-H\XX[7N0&!V(['LYN
ML?9P$T2\,O'>;$SC]&-U7RR2+&?[('2"V8Z8=,3,".;5?VV1GK;8ID?T]'_Z
M\LSA,M*7D\/5_P+9F4 6!;(_1SS%7)XU84=[JL T\>I84F*OW;AY)%WO($G;AJA+=FA\R<;#[5&=.!-)!.5C,UZI,7'8
M'1[(_$J+;U!+ P04    "  $1*5(D*Q$,: !  "Q P  &0   'AL+W=OTKZX'\.1-*^-VM/=^V#+FZAZT
M<#[95B:-7TL"S)6[46MB_
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MV-F>:K!=NCJ.U#@:GS=OJ2ZW\Y&G,WF'5^[email protected]@I;">-(P?TX633H;:('H*)
MXN:6DCZ\GR51T/H8WH?8YBN5$X_#Z8$LK[3Z!U!+ P04    "  $1*5(AR>T
MPIX!  "Q P  &0   'AL+W=OQ-W5S.PL
M']6,]L4- )Z\:F7CSO&7#. %NX.1S#A3X=6"Q]2VS,W6A!M(FG%>%%\
M8%I(0^LJU9YL7>'DE33P9(F;M!;V]P$4SGM:TG/A6?:#CP565VSEM5*#<1(-
ML=#MZ4.Y.VPC(@%^2)C=14RB]R/B2TR^M7M:1 N@H/%1083E!(^@5!0*C7\M
MFF\M(_$R/JM_2=,&]T?AX!'53]GZ(9@M*&FA$Y/RSSA_A66$^RC8H'+I2YK)
M>=1G"B5:O.95FK3.^0_?++3W"7PA\)7PJ4C&7$K3]+EZJLNRJ-@I"EUA#AG#,V9%L*#^;@M^W>+ +^C\W_3-C<--
MHF\6A__1?WLCL$T"V[^.>(VY=6MUO9T//)W)&[RN
M1M'#=V%[:1PYH@\GFPZU0_003!1W]Y0,X?VLB8+.Q_!CB&V^4CGQ.)X?R/I*
MZS]02P,$%     @ !$2E2%SG;8.> 0  L0,  !D   !X;"]W;W)K&ULA5/+;MLP$/P50A\0ZN6T,&0!<[email protected](4FF8 R7;1U<>Q&G3)PW$](P?:P>ZRPK*GKT0A>8?<3D$;,B
MJ%/_LD5^V6*?G]'S[^G%E<,BT(N3P_)[@?)*H P"Y7]'O,1LKIK0LSV5H/MP
M=0QI<%(V;MY:76_G71[.Y!->5R/KX9GIGBM##FC=R89#[1 M.!/IS28A@WL_
M:R*@LS[\X6(=KU1,+([+ UE?:?T/4$L#!!0    (  1$I4C9(U?]HP$  + #
M   9    >&PO=V]R:W-H965TV4JK&/\L]I,M-N$?"+D,V$==H+&1L'F,[.L+#2.Q/3,GUVV=7#M19PR<=Y,
M2,/TL7HLLVQ5T*,7NL#L(R:/F!E!G?K-%OEEBWU^1L]_IB^N'"X"?1'HF\W/
M_.45?QGXRVG"]&PO=V]R:W-H965TZ:EE42$Y"HD
M9:5_7SYDQ38,M!=Q=S4S.\M'-:-YM0. (^]*:KO+!N?&+:6V&4!Q>X2DT/!LB)V4XN;/'B3.NZS(
M3H47T0\N%&A=T977"@7:"M3$0+?+'HKMO@R("/@E8+9G,0G>#XBO(?G1[K(\
M6  )C0L*W"]'> 0I@Y!O_+9H?K0,Q//XI/XM3NO='[B%1Y2_1>L&;S;/2 L=
MGZ1[P?D[+"/UJ%CNN<_K!RH=TFL(7 5L*7/!I/
MC:+-)^YX71FHW6[#+%GMV1F?_IF^N'&XB?;,X_(_^Y95 &07*),#RFR->8JZ;T+,]56#Z
M>'4L:7#2+FW>6EUOYP.+9_(!KZN1]_"3FUYH2P[H_,G&0^T0'7@3^=U]1@;_
M?M9$0N="^-G')EVIE#@<3P]D?:7U7U!+ P04    "  $1*5(+VA=R28"  "-
M!P  &0   'AL+W=O0T[*.
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M"NR$-C/8C=^C$)J9Z.(7TZ>%V8W#I6)';8]S&PO=V]R:W-H965TU#I=4^M,\.#&"M+]0V8?OW
M]86P@)#2%^P9SF7&C,D'J=YU"V#0!V="GZ+6F.Z(L2Y;X$0_R Z$?5-+Q8FQ
MH6JP[A20RI,XPTD<9Y@3*J(B][E75>2R-XP*>%5(]YP3]?<,3 ZG:!?=$F^T
M:8U+X"+'$Z^B'(2F4B %]2EZWAW/F4-XP"\*@Y[MD:O](N6["WY4IRAV)0"#
MTC@%8I!@Y$O
M\RLQI,B5')#NB/MVNZ.%*R=BE9&M3?O0=Q^RUV*79CF^.J$%YAPP2Y5N!TA,+*[W?7I
MAU/\ U!+ P04    "  $1*5(XTW;J20"   D!P  &0   'AL+W=OL"%'@D]%&;H)*J78=AK*L",/R
MA;>DT4^.7#"L]%&<0MD*@@\6Q&B(HF@1,EPW09';V)LH*]/E3*!L,C# 7>H&6EDS1L@R'$3O,+U#B8FQ6;\KDDG1WM@
MBM]S_F$./P^;(#(U$$I*92BP7BYD1R@U3%KY;T]ZTS3 \?[*_MW:U>7OL20[
M3O_4!U7I:J, ',@1GZEZY]T/TGM(#6')J;2_H#Q+Q=D5$@"&/]U:-W;MW)-L
MUZRJRO;UCA(A>\ [+%YFO#M4X7AD0S VU&
MVJ-]72YZ*6"2Y.'%$$URMBX'N9PA(]3L=R705&*+1G!T3V WSDCC>878,Q%;
M?-*;2.<)$H\@L01Q3["8)T@]@G12039UV3B7+B=S.5$49?,R"T]F,9%9SA-D
M'D'VK-&E1[!\P.AR9#3-5ND#,BM/9C616@..JTBC^\TQ
M37J@/R#R=="$ CU X7< C)]VZ_< 3!YQ.TWR>S4<#1]&Q,D.90E*?FZ4:_ A
M.@S^5V2&EQ??F@O!#K4;39&W^$1^87&J&PGV7.G1:*?BD7-%='71BVZQ2E]9
MPX&2HS+;3.^%&^+NH'A[O9.&B['X#U!+ P04    "  $1*5(U(;>8L8!  !"
M!   &0   'AL+W=O@
MT3>C7.V#3NMAA[&J.F!$/8@!N/G2",F(-J%LL1HDD-J1&,5Q&/["C/0\* N7
M>Y-E(49->PYO$JF1,2+_'8"*:1]$P27QWK>=M@E<%GCAU3T#KGK!D81F'SQ%
MNV-J$0[PT<.D5GMD>S\)\66#EWH?A+8%H%!IJT#,QKW9EFPP#5T)"1ZG'?6?.US/1I"RDF) :B+WL
M:&?@THH8963,*!>ZX_+9$6/MPH<
MUX@L^;E"0AK2)+?0KBWX2&Y-YIFC_F]
M%;RZ&P:R=3.K4"5&KKW_);L\BZ?8WNU=_F">BY_NJTQ9#*2%5R+;GBMT$MI,
MCAN:1@@-IK_P(0M09Q[T$E!HM-WF9B_]C/M B^'R8I>_C?(_4$L#!!0    (
M  1$I4C2$L%5" (  %@&   9    >&PO=V]R:W-H965TJ&32RY@T2<-YZS\%F'_@&8A$_:NCDPQP9\P?.WTWP[;3U?.,!*!R5
MD2!ZN,(>*#5*.O-'+WK/:8B/\YOZ%UNNMG\@$O:<_JQ/JM)N?0^=X$PN5+WQ
M[BOT-21&\,BIM$]TO$C%V8WB(48^W5@W=NS$ R%(_TB(>D)T
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MSZW2;7X(*)R5F69Z+ESC&ULC5/)3L,P%/P5
MRQ]09VD+JM)(%(3@@(0XP-EM7AH+VR_8;@-_CYV,V5T'BML9]J#]2HM&<>=+LV>V-\";2%*2%5FV9(H+3>LJ
M]IY-7>'!2:'AV1![4(J;KPU('-8TIZ?&B]AW+C187;&)UP@%V@K4Q$"[IC?Y
M:E,&1 2\"ACL64Z"]RWB>R@>FS7-@@60L'-!@?MPA%N0,@CYP1^CYL_(0#S/
M3^KW<;?>_99;N$7Y)AK7>;,9)0VT_"#="PX/,&YA$01W*&W\DMW!.E0G"B6*
M?Z8H=(Q#6IE?C[2_"<5(*"9"D8RG0='F'7>\[email protected]/8\W%V^\G 31+PR\=YL
M+./N4_=8Y\NR8L<@] NS29ABQ,PG#//Z?PXI+H844:!, OD_!,H+@3(*S$<'
MB]\N=7*9,'D60:$NVZ/P1Q]-M$1UXJ6RVH*3S#WDJ
M)+0NI%<^-^EN4^&P/[W4Z7>IOP%02P,$%     @ !$2E2-,\Z#7P$@  @CT 
M !0   !X;"]S:&%R9613=')I;F=S+GAM;.U;VW+<1I)]'GY%A4*.H2*:+39O
MDB59$30EVHJQ) Y)S^S&Q#X4@>KN6J$!N H@V8[]"\_+_(Z^;$YF%FX-H$D[
MYG$?;+$;=@WWA>J3.TOI3G+RK3X[LGLY.2)NE\EJ?_NR;(H\E?/
MG_MH:5;:3[/??M1NJ@YG$W6P/SOI/UQ/U?[Q\,.'Y/G'Z8TOG(Z*_]F<&09?FH6E
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M4ZALCN^\<9A)?S\].?AV)T5T/[V,>?V'FJ69RQF7[-YYFW1WG7;;L//*@LD5M_8Q!;6],T OR5\
M]2K7:]+:P'-7FB$U]$6>&^P70]VW)BTW5R+L?N5S'9GOGN3!(D_>JNW::TG>
M=PN$SC)+8N/\G]E_BG7?R23:O$1;CM"!DY5&/=V?[N_OSU0.O3+0OU:Z+.!H
M]E<<8+:_/]F7_T(:F"CK/:F!3]]$JSHXFNP?'4Y>'@5':C[*1 4(W^YGIW%L
M">)Q:O*W/?AEI',++0R8HER5"4=H;.8VLCVW$>WY =4,CVSIEP5\S,QM2+%[
MH38MLAXKAL,\BJZ'VO[76@XSI)$.]_8?T# ]NQ@S,9''C5<
M?.910[/Q#-!1U56!?Q@ "_&+I8T0]]"O(51:;FZP1SHM3WMC]J=<^=Y
MDMUML3N/F?.8N^:;8A(#,\CW&'K7E!J
M2XM!SQ\GKQ]9_/F$/9%!6 7;7VMZWRF-V&]@#UP /HH(S$H8!7ER6"&%4I
M^![.CT*9.!3-NMK[KZDZ92FQ>;*>T/0UR(%*,TX621E#/TE"\V3E[I;S+"LP
M%-(Z,J\3ER2Q66;2:V(*,ZBT**_=FG?1:JZM4WG;KHU!PBEB'!0+^I+R;6M5V(HVUC@Q#I80+H)ZDRE2
M793.3%638+%!F11":4GP8NF0_E?2#S'4#U$?.:%7'1!>G519"6QA=HMD%V'!
M6U-IM5JW6"(N5GH-P1EG(W*.:K.Y%+44+[07R8/JTW!6K?:;HMAU:EXZKI=:
MQB*2B.*$G('6ZKCVH$-WC4O+&N9>HU5"A0NW8?D6>]A?L
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MWYL[M;+.\5/)H!QT"&.3R$8I?&@A^<6O/:"2=K0N-/N9M;DCO IZH#$$
MIH!#60O%E(>*UW(,\<$LA;ZK"=-&0^(&JNL&T#4"^L:0T0(\2)Z8D*4"CX4[
MP#U 9")D,9U,6JHAQT.&P[\:%N..E%!\,ABSE;;IILR1 IZQI9<6I7L5-F6!
M2H-Z1M2KJWDE^567Z[*G@?V1F]'0%B4G1YV7J2SA1HIBFD=>UP:F"6NP0430
MB,)R9J5H2"5W2N_P+G-?:$CH+*F\! "AANB<[L^^-T[8J_P=*([('!M"0U7F
M<(;:]0$/1?"?X.V=_!XZL8/':\C[1 H^\O5;,4P=::3S]BP_$"@94Q*B5N!+/U2
M N3LW)KX-:F>ZYSX,;KF1WPR([HCD9;)IC 'U]U4?A&?R2ZSX%CF6D@DV2\U".*>%[J,B6(5Q7RPM
M=)?.PT<.6[,Q\35T38I.B1X@#S)*<%KG?@!.65(SY\Z"8I--S#V%OF@*ED%%
MPQK6*VDL,$TB3M#HIRYC$3SSNIJ8R)+86=]JF_!A[I;(]BF6QX*$>1A>/YSP
MNG L\IR1*KA1J(M&\X+=M%:KC*_GQ1P;RA
M:@O4FU:^7PA0"/=>K:CLUTEH_? 2 ?H5T<+%1I"T$BTR?_=9-WASO:Y;9)0S
M;%IRW<(]'W+W+*V*S8;$7&>*"H%)YY2UFY1P?%=HD))U4[U%&34YN>56?4M]%B((O9-?!MU=8M8BM4.=
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M5R4?!N\?FBLR8Z<,'W^H#
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M#4@0=Y,:*" [4Y-6KIJ7Y(#[P3NB.DIMXMY328)@#F(#F+&S'I)3!U<'0\
M>?FBEPRN'8/96M[/V_YTBWTV!@YK, \7N:S$T!82%?PQ0_5#=?36M_5H:ZPW
MH]I'B*A-2NV&;AL+%I5>%#M]R^\T]X%C+F[K4G4/H;DG'3&GEB:)]XIL;T5%
M.'EM"*W""@%HJ2H.5"OTWYS9,Y1K^(9!\E*0KNG?R=X=B;BD=\Y*UFHRUD0\
ML4QA0.GKT+Q L:U\&$>>B1M-4_;AYDHU=&Z992+.*(9#X,%_*
MM2Z\VJ]'A)K=F:9@-BM;KKB5$%L?7EC@Y$ES$\I^=7TF*!D$ 5_[^1&GH\JC
M;ZJ-PX!)BPKD.C\HH3Z2XWNQ0#$P-]>.[.D.Y#;
MF@3NDEC/%-T24Z-(I.=$&AOJ<]A4+BC#L3:/,PFM!VD.MD[A,VIV>24L*;0H
M?&XB-= .R074ZLKC>O;DG9(M N=X-(WX5TWOB/AS@/?
MHPP$=>^JCUE=>_D[;DU5T]=/&@!YU*"=UGAZ/5OMUF8ATSW;_+P#7C@Y
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M+>#DS#QCR*0J3FXSJ&U% 8)@";6WM!7O^&6W.TSU#ERW(BXZ%1EW
ME.J7/*2GI'OX4[W[0BW=R<#[2WPQV0 1 7FG\'ZJ3J8'"N9(?D\EO7O-+^3U
M7F6\BI8F+N7R[+0YNOK9"_N74V*O684V[A
M;O\/V,. W?3'=M^!@]K$T^OG5]P._<='UE$/C'\*723U.36C@R["A7[GYU@_
M(?+5!ZHC^^-1L="+6(N-3E;OIV3T&X1O-K\]F@U]6PMZ?9>-"GIP,C1U]G+[
M@EQ@C"TY.QI<\G#KDN?4Z!M=\6!H[C@D_"=B_UGC$H._(@E-LA^R+'0*/H&?
MAHZ+N@(T<(JYIG=9=/2@_4?PHZ>(Z8N^'EKHLOGHI4"-FM5ML8,CI)%U#R :
M+-I\UW=GJE*IY>?.1*O_VN NYU%.G
MU,C9JO@S[G_5)=; [PVJ]EJHWT>D_!CN0ZKGZO_4(\XF\E4O3TN1VG?^8+L^
MJ-__@2WK#NE(?^@11NLDID?8>"2WC!J\%;V]TOBJJ<.VF?4QF4J4\J-PJB%:T/ST>,1Z
M?:;8YH;-Z.?>%V__#5!+ 0(4 Q0    (  1$I4C[QI0%D@$  #$1   3    
M          "  0    !;0V]N=&5N=%]4>7!E&UL4$L! A0#%     @ 
M!$2E2$AU!>[%    *P(   L              ( !PP$  %]R96QS+RYR96QS
M4$L! A0#%     @ !$2E2+:A'7%. 0  Q0\  !H              ( !L0( 
M 'AL+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 
M   (  1$I4AO!NB23@(  -8*   -              "  54.  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ !$2E2(NR!9WI @  A@@   \             
M ( !SA   'AL+W=O03  !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#%     @ !$2E2%:R
M2GOP 0  ^ 4  !@              ( !T!D  'AL+W=O&PO=V]R:W-H965T
M&UL4$L! A0#%     @ !$2E2!V ?,6? 0  K0,  !@     
M         ( !9R(  'AL+W=O&PO=V]R:W-H965T&UL4$L!
M A0#%     @ !$2E2'T@H?V? 0  K0,  !@              ( !YR<  'AL
M+W=O&UL4$L! A0#%     @ !$2E2"H[5;R@ 0  K@,  !D              ( !
MDBL  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%   
M  @ !$2E2)"L1#&@ 0  L0,  !D              ( !$C$  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ !$2E2-DC5_VC
M 0  L ,  !D              ( !DS8  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ !$2E2,4B!46_ 0  ? 0  !D     
M         ( !HCP  'AL+W=O&PO=V]R
M:W-H965T&UL
M4$L! A0#%     @ !$2E2-(2P54( @  6 8  !D              ( !\$( 
M 'AL+W=OH4!   Z P  &0              @ $O10  >&PO=V]R:W-H965TM&  !X;"]S:&%R9613=')I;F=S+GAM;%!+!08     (0 A -D(   -
%6@     !
 
end

/** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } };

/* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; }

3.4.0.3 html 23 77 1 false 11 0 false 4 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.SmartGlass.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.SmartGlass.com/role/refr-cbs Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.SmartGlass.com/role/refr-cbsp Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Consolidated Statements of Operations Sheet http://www.SmartGlass.com/role/refr-csoo Consolidated Statements of Operations Statements 4 false false R5.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.SmartGlass.com/role/refr-csocf Consolidated Statements of Cash Flows Statements 5 false false R6.htm 101 - Disclosure - Basis of Presentation Sheet http://www.SmartGlass.com/role/Disclosure-BasisofPresentation Basis of Presentation Notes 6 false false R7.htm 102 - Disclosure - Business Sheet http://www.SmartGlass.com/role/Disclosure-Business Business Notes 7 false false R8.htm 103 - Disclosure - Patent Costs Sheet http://www.SmartGlass.com/role/Disclosure-PatentCosts Patent Costs Notes 8 false false R9.htm 104 - Disclosure - Revenue Recognition Sheet http://www.SmartGlass.com/role/Disclosure-RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 105 - Disclosure - Fee Income Sheet http://www.SmartGlass.com/role/Disclosure-FeeIncome Fee Income Notes 10 false false R11.htm 107 - Disclosure - Stock-Based Compensation Sheet http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensation Stock-Based Compensation Notes 11 false false R12.htm 108 - Disclosure - Income Taxes Sheet http://www.SmartGlass.com/role/Disclosure-IncomeTaxes Income Taxes Notes 12 false false R13.htm 109 - Disclosure - Equity Sheet http://www.SmartGlass.com/role/Disclosure-Equity Equity Notes 13 false false R14.htm 110 - Disclosure - Treasury Stock Sheet http://www.SmartGlass.com/role/Disclosure-TreasuryStock Treasury Stock Notes 14 false false R15.htm 111 - Disclosure - Investments Sheet http://www.SmartGlass.com/role/Disclosure-Investments Investments Notes 15 false false R16.htm 113 - Disclosure - Fair Value Measurements Sheet http://www.SmartGlass.com/role/Disclosure-FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 307 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensation 17 false false R18.htm 311 - Disclosure - Investments (Tables) Sheet http://www.SmartGlass.com/role/Disclosure-InvestmentsTables Investments (Tables) Tables http://www.SmartGlass.com/role/Disclosure-Investments 18 false false R19.htm 40501 - Disclosure - Fee Income (Details) Sheet http://www.SmartGlass.com/role/Disclosure-FeeIncomeDetails Fee Income (Details) Details http://www.SmartGlass.com/role/Disclosure-FeeIncome 19 false false R20.htm 40701 - Disclosure - Stock-Based Compensation (Schedule of Assumptions Used to Value Options Granted to Consultants) (Details) Sheet http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensationScheduleofAssumptionsUsedtoValueOptionsGrantedtoConsultantsDetails Stock-Based Compensation (Schedule of Assumptions Used to Value Options Granted to Consultants) (Details) Details http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensationTables 20 false false R21.htm 40703 - Disclosure - Stock-Based Compensation (Narrative) (Details) Sheet http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensationNarrativeDetails Stock-Based Compensation (Narrative) (Details) Details http://www.SmartGlass.com/role/Disclosure-Stock-BasedCompensationTables 21 false false R22.htm 40901 - Disclosure - Equity (Details) Sheet http://www.SmartGlass.com/role/Disclosure-EquityDetails Equity (Details) Details http://www.SmartGlass.com/role/Disclosure-Equity 22 false false R23.htm 41101 - Disclosure - Investments (Details) Sheet http://www.SmartGlass.com/role/Disclosure-InvestmentsDetails Investments (Details) Details http://www.SmartGlass.com/role/Disclosure-InvestmentsTables 23 false false R24.htm 41301 - Disclosure - Fair Value Measurements (Details) Sheet http://www.SmartGlass.com/role/Disclosure-FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.SmartGlass.com/role/Disclosure-FairValueMeasurements 24 false false All Reports Book All Reports refr-20160331.xml refr-20160331.xsd refr-20160331_cal.xml refr-20160331_def.xml refr-20160331_lab.xml refr-20160331_pre.xml true true

begin 644 0001206774-16-005841-xbrl.zip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email protected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email protected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�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email protected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email protected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email protected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email protected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email protected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email protected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email protected]_^,S,61'R1K]]*XD??O^_?N3\J]; MTCSA$1*9;T_^\>7SU_@!+*,=,503'[?LSN%/>?GC9Q1'1=F RD@>"2GH_QTW M9,?TI^.WWQV_>_N:./&*M-_14=6"&*7@%LR/Z+]_N;WLZ/RZC'#Q*8WR_'6, MEB>4Y 2#.3Z.[_,5L;@44&Q6!$4Y7*Y2T/SV0*@^O"I)OWOS]L3'4M(XD1];=@D>0K0EWC!89=-#$/(&. M;+T X))\>I9@H(DM.8XL^UJ@^ ^*;I"NHMD7..;W MW%%VE(H>9#^*UU3:+$O.LX*TX&4V1WAI/V*7RG,W3X-T":Y @FS0R8O#YW!& MRH:O>MQ;F;SC'3?_7T48D_]X=/3AU]:BZU5[G>Y]Y50&%G3=]7-T#U*UN3Q9 M*<8=473%[SU=\7O[8^E05T/;U%5K>8>NBW;4@^<"9 E([email protected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email protected]>H%<2,@N>G,(O75E>9,@ _>8/LD5W!G2<@0>4.>Z(7DE*TY17MCT+T?O M]""4/,&4O@-S2?S,%I!>8BU+$.PL57SCK62P;_B8R?!X$59DW!V!P\=4?'?' M@+-W#5:#T_N7W@X%:$B !-]X(TNZ5V$U+#B@!%17;J"[XHOJV(*W/-0W19%T MU S\]^6X#![K\79J:.AG$WW&7BU>-:/W7*+1N&A + 1Y0ZRU6Q-7K4-^WL* M:!?3$'Q 7]_R8N5QOP*QMV_1UK3RKO+6H%N0TI/TY3RE+)I\3TUNSO K/M-N MA++?L(%"_7WN=0W_V#9<.19P(]4VR"*IWD<1CK"'[email protected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email protected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email protected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email protected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end

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

AM Best Assigns Credit Ratings to MAAGAP Insurance Inc.

Rubico Announces Termination of $30 Million Equity Line of Credit

The American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient Guidelines

Create E-mail Alert Related Categories
SEC Filings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Form 10-Q RESEARCH FRONTIERS INC For: Mar 31

You May Also Be Interested In

Create E-mail Alert Related Categories

Sign up for StreetInsider Free!

Free News Feed